BKEMV
NDC 55513-180, eculizumab-aeeb, injection, solution, concentrate, from Amgen Inc.
- Product NDC
- 55513-180
- Status
- Listed
- Labeler
- Amgen Inc
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761333
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55513-180 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ECULIZUMAB300 mg/30mL
Pharmacologic classes
Complement Inhibitor [EPC]; Complement Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55513-180-01 | 55513018001 | 1 VIAL in 1 CARTON (55513-180-01) / 30 mL in 1 VIAL |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/002f9748-b0e8-4b6e-a38b-56930a839491Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=55513-180
Use it
Look up 55513-180 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55513-180 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55513-180. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.